-+ 0.00%
-+ 0.00%
-+ 0.00%

OPUS GENETICS - OPGX-BEST1 DEMONSTRATES FAVORABLE SAFETY WITH NO SERIOUS ADVERSE EVENTS OR DOSE-LIMITING TOXICITIES

Reuters·09/09/2026 11:00:02

Please log in to view news